Vytrus Biotech (FRA:V5P) FCF Margin %: 9.14% (As of Dec. 2025) — 46% Above Median


FRA:V5P Vytrus Biotech SA FRA:V5P
63 GF Score
Price €16.70
GF Value €6.81
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Vytrus Biotech FCF Margin %?

Vytrus Biotech FRA:V5P -2.34% 63 FCF Margin % is 9.14% as of Dec. 2025, which is 46% above its 10-year median of 6.28. GuruFocus rates FRA:V5P with a GF Score™ of 63/100 and a GF Value™ of €6.81 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 949 Biotechnology companies, Vytrus Biotech ranks better than 85.77% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vytrus Biotech's Free Cash Flow for the six months ended in Dec. 2025 was €0.37 Mil. Vytrus Biotech's Revenue for the six months ended in Dec. 2025 was €3.99 Mil. Therefore, Vytrus Biotech's FCF Margin % for the quarter that ended in Dec. 2025 was 9.14%.

As of today, Vytrus Biotech's current FCF Yield % is 0.92%.

The historical rank and industry rank for Vytrus Biotech's FCF Margin % or its related term are showing as below:

FRA:V5P' s FCF Margin % Range Over the Past 10 Years
Min: -7.31   Med: 6.28   Max: 14.58
Current: 14.58

During the past 8 years, the highest FCF Margin % of Vytrus Biotech was 14.58%. The lowest was -7.31%. And the median was 6.28%.

FRA:V5P's FCF Margin % is ranked better than
85.77% of 949 companies
in the Biotechnology industry
Industry Median: -82.65 vs FRA:V5P: 14.58

Vytrus Biotech FCF Margin % Related Terms

Vytrus Biotech FCF Margin % Historical Data

* Premium members only.

The historical data trend for Vytrus Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech FCF Margin % Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 6.28 -7.31 -7.01 12.69 14.58

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.92 0.72 24.47 19.55 9.14

FRA:V5P vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Vytrus Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vytrus Biotech FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vytrus Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vytrus Biotech's FCF Margin % falls into.


FRA:V5P
63GF Score
Vytrus Biotech SA FRA:V5P
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vytrus Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vytrus Biotech's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=1.221/8.372
=14.58 %

Vytrus Biotech's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.365/3.994
=9.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 9.14% mean?
Vytrus Biotech (FRA:V5P) has a FCF Margin % of 9.14% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vytrus Biotech and its competitors. This is 46% above median its historical median of 6.28. According to the industry distribution chart, Vytrus Biotech ranks #135 out of 949 companies in the Biotechnology industry, placing it in the top 14.2%.
Is Vytrus Biotech's FCF Margin % too high?
Vytrus Biotech's current FCF Margin % of 9.14% is 46% above median its 10-year median of 6.28. Based on the distribution chart, Vytrus Biotech ranks #135 out of 949 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Vytrus Biotech has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vytrus Biotech's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vytrus Biotech ranks #135 out of 949 companies for FCF Margin %. This places Vytrus Biotech in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Vytrus Biotech and its competitors. Vytrus Biotech's current FCF Margin % is 9.14%, which is 46% above median its own 10-year median of 6.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vytrus Biotech stock overvalued right now?
Based on GuruFocus' analysis, Vytrus Biotech (FRA:V5P) is currently considered Significantly Overvalued. The stock's GF Value™ is €6.81, compared to a current price of €16.70 — trading 145.2% above its estimated fair value. The current FCF Margin % is 9.14%, which is 46% above median its 10-year median of 6.28. Vytrus Biotech's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Vytrus Biotech (FRA:V5P), the current FCF Margin % is 9.14% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vytrus Biotech (FRA:V5P) Overvalued in 2026?

Based on GuruFocus' analysis, Vytrus Biotech stock appears to be overvalued. The current stock price of €16.70 is trading 145.2% above its estimated GF Value™ of €6.81. GuruFocus considers Vytrus Biotech to be Significantly Overvalued.

Key valuation signals for FRA:V5P:

  • FCF Margin %: 9.14% (46% above median its 10-year median of 6.28)
  • GF Value™: €6.81 vs. price of €16.70 (145.2% above fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the FRA:V5P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vytrus Biotech Business Description

Other Exchanges VYT:Spain
Address Sant Gaieta 121, 2nd Floor, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.
63GF Score

Get the complete analysis for FRA:V5P

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.70
Price
€6.81
GF Value